The Defender Children’s Health Defense News and Views
Close menu
Close menu

You must be a CHD Insider to save this article Sign Up

Already an Insider? Log in

November 20, 2026 › Health Conditions › Views

Health Conditions

Children’s Health Defense Urges Autism Committee to Probe Environmental Contributors to Autism

The federal Interagency Autism Coordinating Committee met late today for ongoing discussions around the agency’s new strategic plan. Children’s Health Defense Chief Scientific Officer Brian Hooker submitted public comments for the meeting. The Defender will have complete coverage of today’s meeting on Monday, Nov. 23.

Brian Hooker and puzzle pieces

Editor’s note: Children’s Health Defense (CHD) Chief Scientific Officer Brian Hooker submitted public comments for today’s meeting of the federal Interagency Autism Coordinating Committee. Below is a summary of Hooker’s comments submitted on behalf of CHD. Click here to read the full document.

Children’s Health Defense supports the direction of the 2026–2028 IACC Strategic Plan and encourages its full implementation.

We particularly welcome its attention to profound autism, co-occurring medical conditions, improved treatment, and the need for a more comprehensive understanding of autism across the lifespan.

We believe the next important step is to translate these priorities into a robust research agenda that examines the full range of potential biological and environmental contributors to autism and develops treatments that address the medical and physiological needs of affected individuals.

Families of individuals with severe autism deserve more than a research agenda focused primarily on diagnosis and symptom management. They deserve a sustained commitment to understanding the underlying biology of autism, identifying potentially modifiable contributors, and developing safe and effective treatments.

This includes rigorous investigation of vaccines and vaccine components, agricultural chemicals, food and water contaminants, medications such as acetaminophen, and the complex relationship between human physiology and the gut microbiome.

It also requires recognizing motor dysfunction as an important area of study and ensuring that individuals with the most substantial support needs are not left behind.

This article was funded by critical thinkers like you.

The Defender is 100% reader-supported. No corporate sponsors. No paywalls. Our writers and editors rely on you to fund stories like this that mainstream media won’t write.

Please Donate Today

We urge the IACC to carry these priorities forward as part of its implementation of the 2026–2028 Strategic Plan.

We appreciate the Committee’s work and its commitment to advancing autism research, improving medical care, and supporting individuals with autism and their families.

Read the entire public comment here.

Share Options

Add to Google
Suggest A Correction
Close menu

Republish Article

Please use the HTML above to republish this article. It is pre-formatted to follow our republication guidelines. Among other things, these require that the article not be edited; that the author’s byline is included; and that The Defender is clearly credited as the original source.

Please visit our full guidelines for more information. By republishing this article, you agree to these terms.

Woman drinking coffee looking at phone

Join hundreds of thousands of subscribers who rely on The Defender for their daily dose of critical analysis and accurate, nonpartisan reporting on Big Pharma, Big Food, Big Chemical, Big Energy, and Big Tech and
their impact on children’s health and the environment.

  • This field is for validation purposes and should be left unchanged.